-
AWS HealthImaging integration delivers standards-based digital pathology at enterprise scale with DICOM and Proscia’s cloud-native platform
Sep 15, 2025
-
Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.
Sep 10, 2025
-
UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.
Sep 8, 2025
-
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII assay in anticipation of emerging hemophilia treatments such as Mim8, a next generation bispecific antibody for the treatment of hemophilia A. The updated assay will ensure labs are ready and able to deliver accurate results when new treatments become available.
Sep 9, 2025
-
• Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
• Kits incorporate Thermo Fisher Scientific’s CaptureSelect affinity reagents for enhanced specificity and consistency
Sep 8, 2025
-
Logical Biological, biospecimen and critical raw material leader, and Bcell Design, pioneers in transgenic monoclonal antibody technology, today announced a long term strategic partnership to deliver engineered disease state materials for diagnostic and research markets.
Sep 9, 2025
-
For participating academic medical centers, healthcare systems, and reference laboratories, Proscia Aperture elevates pathology from a diagnostic function to a strategic revenue driver.
Sep 8, 2025
-
Gifthealth today announced its acquisition of Occam Health Services creating the first-of-its-kind digital pharmacy platform and patient access hub solution fundamentally shifting how biopharma companies accelerate access and value for patients.
Sep 4, 2025
-
One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.
Sep 3, 2025
-
Sep 2, 2025
-
Sep 2, 2025
-
Aug 27, 2025
-
Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
Aug 26, 2025
-
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced its participation in the 2025 Advances in Genome Biology and Technology (AGBT) Precision Health Conference, taking place September 8–10, 2025, in San Diego, CA. The company will present important data underscoring the clinical utility of RNA sequencing in the diagnosis of rare and previously undiagnosed diseases.
Aug 24, 2025
-
Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
Aug 20, 2025
-
Aug 19, 2025
-
Aug 14, 2025
-
Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced a clinical webinar highlighting pediatric cases in which Whole Genome Sequencing (WGS) delivered diagnostic insights that traditional genetic testing methods could not achieve.
Aug 13, 2025
-
Aug 12, 2025
-
VieCure adds Summit Cancer Centers to community oncology care network
Aug 4, 2025